Nitric oxide in the pathogenesis of sepsis (Q33642564)

28 July 2017

1 reference

title

Nitric oxide in the pathogenesis of sepsis (English)

1 reference

28 July 2017

0 references

Symeonides S

1

1 reference

28 July 2017

Balk RA

series ordinal

2

1 reference

28 July 2017

publication date

1 June 1999

1 reference

Infectious Disease Clinics of North America

28 July 2017

published in

1 reference

28 July 2017

volume

13

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

449-63, x

1 reference

Epinephrine impairs splanchnic perfusion in septic shock

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Pulmonary hypertension and reduced cardiac output during inhibition of nitric oxide synthesis in human septic shock.

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Prolonged inhibition of nitric oxide synthesis in severe septic shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Effect of L-NAME, an inhibitor of nitric oxide synthesis, on cardiopulmonary function in human septic shock.

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Control of cardiac muscle cell function by an endogenous nitric oxide signaling system

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

The pathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Sepsis: A New Hypothesis for Pathogenesis of the Disease Process

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide as a target for therapy in septic shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide and septic shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Pyridoxalated hemoglobin polyoxyethylene conjugate does not restore hypoxic pulmonary vasoconstriction in ovine sepsis

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric Oxide Synthase Inhibition Restores Hypoxic Pulmonary Vasoconstriction in Sepsis

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide synthase as a therapeutic target in sepsis--more questions than answers?

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Role of nitric oxide in the regulation of myocardial function

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide inhibition in the treatment of septic shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

L-NMMA Increases blood pressure in man

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

A yellow light for nitric oxide synthase inhibitors in sepsis: proceed with caution

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide overproduction in septic shock-Methemoglobin concentrations and blockade with diaspirin cross-linked hemoglobin

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Guanylate-cyclase-mediated inhibition of cardiac ICa by carbachol and sodium nitroprusside

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Role of nitric oxide in the hemodynamic changes of sepsis

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide and vascular disease

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide: a physiologic messenger

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

The L-arginine-nitric oxide pathway

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitrogen oxide levels in patients after trauma and during sepsis

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Profound but reversible myocardial depression in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Arrest of endotoxin-induced hypotension by transforming growth factor beta1.

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Effects of a nitric oxide synthase inhibitor in humans with septic shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Methylene blue administration in septic shock: a clinical trial.

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb[trademark symbol]) as a vasopressor in critically ill patients

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Modulation of cyclic guanosine monophosphate production during Escherichia coli septic shock.

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Selective iNOS Inhibition Is Superior to Norepinephrine in the Treatment of Rat Endotoxic Shock

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide production in experimental gram-negative infection: studies with cytokine receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Role of nitric oxide in the regulation of oxygen consumption in conscious dogs

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

N(G)-monomethyl-L-arginine improves survival in a pig model of abdominal sepsis

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Differential effect of 2-aminoethyl-isothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion and endotoxemia.

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016/S0891-5520(05)70085-4

7 January 2021

10.1016/S0891-5520(05)70085-4

Identifiers

DOI

1 reference

28 July 2017

1 reference